Journal of Clinical Case Reports and Images
Open Access
Lenalidomide-Induced High Grade Fever in a Patient with Multiple Myeloma: A Case Report
Mar 2019 DOI 10.14302/issn.2641-5518.jcci-19-2664
Ghada ElGoharyCorresponding author
Lenalidomide is a second generation immunomodulatory agent and a potent analogue of thalidomide that is FDA approved mainly for the treatment of multiple myeloma (MM) and transfusion-dependent anemia due to low or intermediate-1- risk myelodysplastic syndromes (MDS) associated with 5q deletion among…